GPC3 and hepatocellular carcinoma: It would be interesting to know whether the mRNA expression patterns of GPC3, LYVE1, and survivin suffer from the same sort of intratumoral heterogeneity, which might complicate their use as molecular markers for HCC in needle biopsies.